National Bank of Canada
RDY icon

National Bank of Canada’s Dr. Reddy's Laboratories RDY Stock Holding History

National Bank of Canada’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-86
Closed -$1.2K – 3095
2025
Q3 		$1.2K Sell
86
-14
-14% -$201 ﹤0.01% 2635
2025
Q2 		$1.5K Sell
100
-70,900
-100% -$1.01M ﹤0.01% 2648
2025
Q1 		$936K Buy
71,000
+54,536
+331% +$752K ﹤0.01% 1210
2024
Q4 		$260K Buy
16,464
+469
+3% +$7.05K ﹤0.01% 1558
2024
Q3 		$50.8K Sell
15,995
-904,605
-98% -$14.6M ﹤0.01% 1701
2024
Q2 		$13.9M Buy
920,600
+413,620
+82% +$5.93M 0.02% 478
2024
Q1 		$7.01M Buy
506,980
+490,435
+2,964% +$7.16M 0.01% 706
2023
Q4 		$234K Buy
16,545
+210
+1% +$2.81K ﹤0.01% 1407
2023
Q3 		$217K Buy
16,335
+365
+2% +$4.94K ﹤0.01% 1472
2023
Q2 		$202K Sell
15,970
-2,655
-14% -$31K ﹤0.01% 1463
2023
Q1 		$214K Buy
+18,625
New +$201K ﹤0.01% 1395
2022
Q4 		– Sell
-135,500
Closed -$1.42M – 2875
2022
Q3 		$1.42M Buy
+135,500
New +$1.44M 0.01% 869
2022
Q1 		– Sell
-51,320
Closed -$672K – 2990
2021
Q4 		$672K Buy
+51,320
New +$647K ﹤0.01% 1168

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

National Bank of Canada's RDY Position: Q4 2025 in Review

National Bank of Canada sold out of Dr. Reddy's Laboratories (RDY) in Q4 2025, closing a stake of 86 shares — an estimated $1.2K sold.

National Bank of Canada first reported a position in RDY in Q4 2021 and held it in 13 quarters. The position peaked at $13.9M in Q2 2024. 236 funds tracked by Wall St. Rank hold RDY as of Q4 2025.

  • National Bank of Canada reported no remaining Dr. Reddy's Laboratories position as of Q4 2025 after selling out during the quarter.
  • National Bank of Canada sold 86 Dr. Reddy's Laboratories shares in Q4 2025, an estimated $1.2K.
  • National Bank of Canada first reported a position in Dr. Reddy's Laboratories in Q4 2021 and held it in 13 quarters.
  • National Bank of Canada's Dr. Reddy's Laboratories position peaked at $13.9M in Q2 2024.
  • 236 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2025.

Based on National Bank of Canada's 13F filing for Q4 2025, filed 17 Feb 2026.